Navigation Links
Biomoda Hires Manzano Strategies LLC to Spearhead Government Affairs Efforts

ALBUQUERQUE, N.M., Oct. 31 /PRNewswire-FirstCall/ -- Biomoda, Inc. (OTC Bulletin Board: BMOD) ( of Albuquerque, NM, maker of early lung cancer detection testing and other cancer diagnostic technology, announced today it hired Manzano Strategies LLC, a government consulting firm focused on building government partnerships with companies interested in defense appropriations and development of advanced technologies.

Manzano Strategies' ( partners David Montoya and Bruce Donisthorpe will spearhead efforts with the New Mexico legislature and federal government in promoting programs using Biomoda's early lung cancer detection technology based on a patented porphyrin application that preferentially binds to cancerous or aberrant cells extracted from lung sputum samples. Cancerous cells glow red under fluorescent light to allow detection under a microscope.

Before launching Manzano Strategies, Montoya served as Chief of Staff of Los Alamos National Laboratory's Nuclear Weapons Program. He served as a senior policy advisor to Senator Jeff Bingaman, responsible for defense, veterans' affairs, economic development and other programs. Donisthorpe was Legislative Director for Representative Joe Skeen and an Associate Staff Member of the US House Appropriations Committee prior to entering private business as a government affairs advisor for New Mexico Institute of Mining and Technology (New Mexico Tech), among other high-technology and defense- related clients.

"David and Bruce represent two of the best advisors in the country related to our work with the government in securing support for programs that will help our veterans and the military in the field of health care," said John Cousins, President of Biomoda. "We look forward to using every bit of their expertise in promoting Biomoda on a national scale."

Biomoda's, the patented technology, a non-invasive cytology based assay, is designed for cancer screening of large populations at a reasonable cost. Current diagnostic methods for lung cancer, including CT scans and X-rays, often detect the disease only at more advanced stages and are relatively expensive.

Lung cancer claims more lives than any other cancer. The expected 5-year survival rate for all patients combined in whom lung cancer is diagnosed is 15 percent and by contrast, the 5-year survival rate for cases detected when the disease is still localized is 50 percent. At the present time, only 16 percent of lung cancer cases are diagnosed at this early stage.

Contact: John Cousins (505) 821-0875

SOURCE Biomoda, Inc.
Copyright©2007 PR Newswire.
All rights reserved

Related biology technology :

1. Germantown drug company hires pharma veteran James Davidson as COO
2. Merge Healthcare hires new VP of finance
3. PDS hires new VP, buys former health club building
4. Strategies to Identify and Confirm Phase I Metabolites of Glyburide Using the 4000 Q TRAP System
5. Going for the "Big Score" or hedging your bets: Two economic development strategies
6. Innovative Health Strategies near Milwaukee set to profit from Medicare expansion
7. Entrepreneurs Conference to focus on strategies, tools and culture
8. Sales Strategies for the High-Tech Entrepreneur
9. Spend Money to Make Money and Dump Obsolete Tech Strategies
10. Institute Helps Industries Enhance Business Strategies
11. GameBased Learning Strategies
Post Your Comments:
(Date:12/1/2015)... Dec. 1, 2015 Cepheid (Nasdaq: CPHD ... at the Piper Jaffray Healthcare Conference in ... Company is reaffirming its outlook for the fourth quarter ... addition to discussing longer term business model expectations. ... Officer.  "We continue to be the fastest growing company ...
(Date:12/1/2015)... , December 1, 2015 ... of the  "2016 U.K. Virology and Bacteriology ... for 100 Tests, Supplier Shares by Test, ... to their offering.  --> ... "2016 U.K. Virology and Bacteriology Testing Market: ...
(Date:11/30/2015)... MIAMI (PRWEB) , ... November 30, 2015 , ... Global Stem Cells Group ... new clinics in the cities of Arica and Iquique in northern Chile. The facilities are ... clinics offer the most advanced protocols and techniques in stem cell medicine to patients from ...
(Date:11/30/2015)... ALBANY, N.Y. , Nov. 30, 2015 /PRNewswire-USNewswire/ ... led by assistant chemistry professor Jan Halámek, is ... level.   --> ...   --> ... researchers at UAlbany have discovered a straightforward concept ...
Breaking Biology Technology:
(Date:11/10/2015)... , Nov. 10, 2015  In this ... the basis of product, type, application, disease ... in this report are consumables, services, software. ... are safety biomarkers, efficacy biomarkers, and validation ... report are diagnostics development, drug discovery and ...
(Date:11/4/2015)... ALBANY, New York , November 4, 2015 /PRNewswire/ ... According to a new market report published by Transparency ... Size, Share, Growth, Trends and Forecast 2015 - 2022", ... value of US$ 30.3 bn by 2022. The market ... during the forecast period from 2015 to 2022. Rising ...
(Date:10/29/2015)... 2015 Daon, a global leader in mobile ... a new version of its IdentityX Platform , ... America have already installed IdentityX v4.0 and ... FIDO UAF certified server component as an ... FIDO features. These customers include some of the largest ...
Breaking Biology News(10 mins):